Guidelines for good pharmacoepidemiology practices (GPP)

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 8, 2005, Pages 589-595

  Epstein, Mark ^a  

^a International Society of Pharmacoepidemiology (ISPE)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; VACCINE;

CLINICAL PROTOCOL; CLINICAL TRIAL; DATA ANALYSIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; GOOD CLINICAL PRACTICE; HEALTH CARE FACILITY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; NOTE; OUTCOMES RESEARCH; PERSONNEL MANAGEMENT; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY CONTROL; RESOURCE MANAGEMENT; RESPONSIBILITY; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMMUNICATION; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC METHODS; GOALS; INFORMATION STORAGE AND RETRIEVAL; PHARMACOEPIDEMIOLOGY; POPULATION; QUALITY CONTROL; RESEARCH DESIGN; RESEARCH SUBJECTS;

EID: 23844544929     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1082     Document Type: Note

References (2)

1. Chemical Manufacturers Association's Epidemiology Task Group. Guidelines for good epidemiology practices for occupational environmental epidemiologic research. JOM 1991; 33: 1221-1229.
2. Austin MA, Ordovas JM, Eckfeldt JH, et al. Guidelines of the National Heart, Lung, and Blood Institute Working Group on blood drawing, processing, and storage for genetic studies. Am J Epidemiol 1996; 144: 437-441.